• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于真实数据的截至 2021 年 12 月德国 561379 例住院 COVID-19 患者的特征和死亡率。

Characteristics and mortality of 561,379 hospitalized COVID-19 patients in Germany until December 2021 based on real-life data.

机构信息

Department of Anaesthesiology, Intensive Care Medicine and Pain Therapy, University Hospital Frankfurt, Goethe University, Theodor-Stern Kai 7, 60590, Frankfurt, Germany.

出版信息

Sci Rep. 2022 Jul 1;12(1):11116. doi: 10.1038/s41598-022-15287-3.

DOI:10.1038/s41598-022-15287-3
PMID:35778464
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9247915/
Abstract

The ongoing SARS-CoV-2 pandemic is characterized by poor outcome and a high mortality especially in the older patient cohort. Up to this point there is a lack of data characterising COVID-19 patients in Germany admitted to intensive care (ICU) vs. non-ICU patients. German Reimbursement inpatient data covering the period in Germany from January 1st, 2020 to December 31th, 2021 were analyzed. 561,379 patients were hospitalized with COVID-19. 24.54% (n = 137,750) were admitted to ICU. Overall hospital mortality was 16.69% (n = 93,668) and 33.36% (n = 45,947) in the ICU group. 28.66% (n = 160,881) of all patients suffer from Cardiac arrhythmia and 17.98% (n = 100,926) developed renal failure. Obesity showed an odds-ratio ranging from 0.83 (0.79-0.87) for WHO grade I to 1.13 (1.08-1.19) for grade III. Mortality-rates peaked in April 2020 and January 2021 being 21.23% (n = 4539) and 22.99% (n = 15,724). A third peak was observed November and December 2021 (16.82%, n = 7173 and 16.54%, n = 9416). Hospitalized COVID-19 patient mortality in Germany is lower than previously shown in other studies. 24.54% of all patients had to be treated in the ICU with a mortality rate of 33.36%. Congestive heart failure was associated with a higher risk of death whereas low grade obesity might have a protective effect on patient survival. High admission numbers are accompanied by a higher mortality rate.

摘要

目前,关于德国重症监护病房(ICU)与非 ICU 收治的 COVID-19 患者的数据尚不清楚。本研究分析了德国从 2020 年 1 月 1 日至 2021 年 12 月 31 日期间的医保住院数据。共 561379 例 COVID-19 患者住院,其中 24.54%(n=137750)被收入 ICU。总体院内死亡率为 16.69%(n=93668),ICU 组死亡率为 33.36%(n=45947)。所有患者中有 28.66%(n=160881)患有心律失常,17.98%(n=100926)发生肾衰竭。肥胖的 OR 值范围从 WHO 1 级的 0.83(0.79-0.87)到 3 级的 1.13(1.08-1.19)。死亡率在 2020 年 4 月和 2021 年 1 月达到峰值,分别为 21.23%(n=4539)和 22.99%(n=15724)。2021 年 11 月和 12 月出现第三次高峰,死亡率分别为 16.82%(n=7173)和 16.54%(n=9416)。德国 COVID-19 住院患者的死亡率低于之前其他研究报道。所有患者中有 24.54%需要在 ICU 治疗,死亡率为 33.36%。充血性心力衰竭与死亡风险增加相关,而轻度肥胖可能对患者生存有保护作用。高入院人数伴随着更高的死亡率。

相似文献

1
Characteristics and mortality of 561,379 hospitalized COVID-19 patients in Germany until December 2021 based on real-life data.基于真实数据的截至 2021 年 12 月德国 561379 例住院 COVID-19 患者的特征和死亡率。
Sci Rep. 2022 Jul 1;12(1):11116. doi: 10.1038/s41598-022-15287-3.
2
Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.意大利伦巴第地区 1591 名 ICU 收治的 SARS-CoV-2 感染患者的基线特征和结局。
JAMA. 2020 Apr 28;323(16):1574-1581. doi: 10.1001/jama.2020.5394.
3
Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variant Predominance - One Hospital, California, July 15-September 23, 2021, and December 21, 2021-January 27, 2022.2021 年 7 月 15 日至 9 月 23 日和 2021 年 12 月 21 日至 2022 年 1 月 27 日期间,加利福尼亚州一家医院因实验室确诊的 SARS-CoV-2 感染住院的成年人的临床特征和结局,期间 B.1.617.2(德尔塔)和 B.1.1.529(奥密克戎)变异株占主导地位。
MMWR Morb Mortal Wkly Rep. 2022 Feb 11;71(6):217-223. doi: 10.15585/mmwr.mm7106e2.
4
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.COVID-19 住院成人患者使用伊马替尼的安全性和疗效:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9.
5
Pressure on the Health-Care System and Intensive Care Utilization During the COVID-19 Outbreak in the Lombardy Region of Italy: A Retrospective Observational Study in 43,538 Hospitalized Patients.意大利伦巴第地区 COVID-19 爆发期间医疗系统压力和重症监护利用情况:43538 例住院患者的回顾性观察研究。
Am J Epidemiol. 2022 Jan 1;191(1):137-146. doi: 10.1093/aje/kwab252.
6
Mortality in hospitalized COVID-19 patients was associated with the COVID-19 admission rate during the first year of the pandemic in Sweden.在瑞典大流行的第一年,住院 COVID-19 患者的死亡率与 COVID-19 入院率相关。
Infect Dis (Lond). 2022 Feb;54(2):145-151. doi: 10.1080/23744235.2021.1983643. Epub 2021 Oct 6.
7
Predictors of Intensive Care Unit Admission among Hospitalized COVID-19 Patients in a Large University Hospital in Tehran, Iran.伊朗德黑兰一家大型大学医院中住院的新冠肺炎患者重症监护病房收治的预测因素
J Res Health Sci. 2021 Feb 21;21(1):e00510. doi: 10.34172/jrhs.2021.44.
8
Association of obesity with illness severity in hospitalized patients with COVID-19: A retrospective cohort study.肥胖与 COVID-19 住院患者疾病严重程度的关联:一项回顾性队列研究。
Obes Res Clin Pract. 2021 Mar-Apr;15(2):172-176. doi: 10.1016/j.orcp.2021.02.006. Epub 2021 Feb 25.
9
Characteristics and outcome of critically ill patients with coronavirus disease-2019 (COVID-19) pneumonia admitted to a tertiary care center in the United Arab Emirates during the first wave of the SARS-CoV-2 pandemic. A retrospective analysis.在 2019 年冠状病毒病(COVID-19)肺炎危重症患者的特征和结局中,阿联酋一家三级保健中心在 SARS-CoV-2 大流行的第一波期间收治的患者。一项回顾性分析。
PLoS One. 2021 Oct 22;16(10):e0251687. doi: 10.1371/journal.pone.0251687. eCollection 2021.
10
Patient characteristics, clinical course and factors associated to ICU mortality in critically ill patients infected with SARS-CoV-2 in Spain: A prospective, cohort, multicentre study.西班牙感染新型冠状病毒肺炎(SARS-CoV-2)的危重症患者的特征、临床病程及与重症监护病房(ICU)死亡率相关的因素:一项前瞻性队列多中心研究
Rev Esp Anestesiol Reanim (Engl Ed). 2020 Oct;67(8):425-437. doi: 10.1016/j.redar.2020.07.003. Epub 2020 Jul 13.

引用本文的文献

1
Critical risks of haemoadsorption for COVID-19 patients and directions for future evaluations: a nationwide propensity score matched cohort study.COVID-19患者血液吸附的关键风险及未来评估方向:一项全国性倾向评分匹配队列研究
Sci Rep. 2025 Aug 9;15(1):29184. doi: 10.1038/s41598-025-13860-0.
2
Time-series metabolomic profiling of SARS-CoV-2 infection: Possible prognostic biomarkers in patients in the ICU by ¹H-NMR analysis.2019冠状病毒病感染的时间序列代谢组学分析:通过¹H-NMR分析确定重症监护病房患者可能的预后生物标志物
PLoS One. 2025 Jul 3;20(7):e0327244. doi: 10.1371/journal.pone.0327244. eCollection 2025.
3
Cost-effectiveness Analysis of Nirmatrelvir/Ritonavir for COVID-19 Among Individuals at High Risk: A Modeling Study.

本文引用的文献

1
Local and systemic responses to SARS-CoV-2 infection in children and adults.儿童和成人中对 SARS-CoV-2 感染的局部和全身反应。
Nature. 2022 Feb;602(7896):321-327. doi: 10.1038/s41586-021-04345-x. Epub 2021 Dec 22.
2
Clinical Practice Guideline: Recommendations on the In-hospital Treatment of Patients with COVID-19.临床实践指南:关于 COVID-19 患者住院治疗的建议。
Dtsch Arztebl Int. 2021 Dec 27;118(50):865-871. doi: 10.3238/arztebl.m2021.0374.
3
Effectiveness of extended shutdown measures during the ´Bundesnotbremse´ introduced in the third SARS-CoV-2 wave in Germany.
奈玛特韦/利托那韦用于高危人群新冠治疗的成本效益分析:一项建模研究
Open Forum Infect Dis. 2025 Mar 26;12(4):ofaf187. doi: 10.1093/ofid/ofaf187. eCollection 2025 Apr.
4
Health-economic evaluation of the outpatient, inpatient, and public health sector in Germany: Insights from the first three COVID-19 waves.德国门诊、住院和公共卫生部门的卫生经济评估:来自前三波新冠疫情的见解
PLoS One. 2025 Feb 7;20(2):e0314164. doi: 10.1371/journal.pone.0314164. eCollection 2025.
5
Long-term mortality of Dutch COVID-19 patients admitted to the intensive care medicine: a retrospective analysis from a national quality registry.荷兰重症监护医学科收治的新冠肺炎患者的长期死亡率:一项基于国家质量登记处的回顾性分析。
Crit Care Sci. 2024 Dec 20;36:e202400251en. doi: 10.62675/2965-2774.20240251-en. eCollection 2024.
6
Polyuria in COVID-19 Patients Undergoing Extracorporeal Membrane Oxygenation.接受体外膜肺氧合治疗的新冠肺炎患者的多尿症
J Clin Med. 2024 Jul 12;13(14):4081. doi: 10.3390/jcm13144081.
7
Lessons Learned from Model-based Economic Evaluations of COVID-19 Drug Treatments Under Pandemic Circumstances: Results from a Systematic Review.基于模型的 COVID-19 药物治疗在大流行情况下的经济评估的经验教训:系统评价的结果。
Pharmacoeconomics. 2024 Jun;42(6):633-647. doi: 10.1007/s40273-024-01375-x. Epub 2024 May 10.
8
Chronic Anticoagulation in Patients with Atrial Fibrillation and COVID-19: A Systematic Review and Meta-Analysis.慢性抗凝治疗在伴有 COVID-19 的心房颤动患者中的应用:系统评价和荟萃分析。
Arq Bras Cardiol. 2024 Apr 26;121(3):e20230470. doi: 10.36660/abc.20230470. eCollection 2024.
9
Mechanical ventilation as a major driver of COVID-19 hospitalization costs: a costing study in a German setting.机械通气作为新冠病毒疾病住院费用的主要驱动因素:一项德国环境下的成本研究
Health Econ Rev. 2024 Jan 16;14(1):4. doi: 10.1186/s13561-023-00476-1.
10
High-dose methylprednisolone pulse therapy during refractory COVID-19 acute respiratory distress syndrome: a retrospective observational study.大剂量甲基强的松龙脉冲疗法治疗难治性 COVID-19 急性呼吸窘迫综合征:一项回顾性观察研究。
BMC Pulm Med. 2023 Oct 3;23(1):368. doi: 10.1186/s12890-023-02664-5.
德国在第三波 SARS-CoV-2 疫情中引入“联邦制动”期间延长封锁措施的效果。
Infection. 2021 Dec;49(6):1331-1335. doi: 10.1007/s15010-021-01713-7. Epub 2021 Oct 20.
4
A global country-level analysis of the relationship between obesity and COVID-19 cases and mortality.全球国家层面肥胖与 COVID-19 病例和死亡率关系的分析。
Diabetes Obes Metab. 2021 Dec;23(12):2697-2706. doi: 10.1111/dom.14523. Epub 2021 Aug 25.
5
Incidence, Predictors, and Outcomes of In-Hospital Cardiac Arrest in COVID-19 Patients Admitted to Intensive and Non-Intensive Care Units: Insights From the AHA COVID-19 CVD Registry.COVID-19 患者入住重症监护病房和非重症监护病房中心脏骤停的发生率、预测因素和结局:来自 AHA COVID-19 CVD 登记处的见解。
J Am Heart Assoc. 2021 Aug 17;10(16):e021204. doi: 10.1161/JAHA.120.021204. Epub 2021 Aug 11.
6
[The different periods of COVID-19 in Germany: a descriptive analysis from January 2020 to February 2021].[德国新冠肺炎的不同时期:2020年1月至2021年2月的描述性分析]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2021 Sep;64(9):1093-1106. doi: 10.1007/s00103-021-03394-x. Epub 2021 Aug 10.
7
Obesity and mortality in critically ill COVID-19 patients with respiratory failure.肥胖与新冠肺炎呼吸衰竭危重症患者的死亡率。
Int J Obes (Lond). 2021 Sep;45(9):2028-2037. doi: 10.1038/s41366-021-00872-9. Epub 2021 Jun 10.
8
Mortality after in-hospital cardiac arrest in patients with COVID-19: A systematic review and meta-analysis.COVID-19 住院心搏骤停患者的死亡率:系统评价和荟萃分析。
Resuscitation. 2021 Jul;164:122-129. doi: 10.1016/j.resuscitation.2021.04.025. Epub 2021 May 5.
9
Body Mass Index and Risk for COVID-19-Related Hospitalization, Intensive Care Unit Admission, Invasive Mechanical Ventilation, and Death - United States, March-December 2020.体重指数与 2020 年 3 月至 12 月期间 COVID-19 相关住院、重症监护病房收治、有创机械通气和死亡风险的关系-美国。
MMWR Morb Mortal Wkly Rep. 2021 Mar 12;70(10):355-361. doi: 10.15585/mmwr.mm7010e4.
10
Obesity and Mortality Among Patients Diagnosed With COVID-19: A Systematic Review and Meta-Analysis.新冠病毒疾病确诊患者的肥胖与死亡率:一项系统综述和荟萃分析
Front Med (Lausanne). 2021 Feb 5;8:620044. doi: 10.3389/fmed.2021.620044. eCollection 2021.